Literature DB >> 34326419

Association between short-term heart rate variability and blood coagulation in patients with breast cancer.

Lingling Wang1,2, Jingfeng Wang1,2, Peng Li3,4, Xiangzhi Wang1, Shuang Wu5, Bo Shi6,7.   

Abstract

The purpose of this study was to investigate the relationship between heart rate variability (HRV), a non-invasive tool for evaluating autonomic function, and routine coagulation indices (RCIs) in patients with breast cancer (BC). Forty-six BC patients were enrolled in this study. Blood biochemistry tests were performed to extract RCIs, including prothrombin time (PT), activated partial thromboplastin time (APTT), and thrombin time (TT). Five-minute electrocardiograms were collected for analysis of HRV parameters (SDNN, RMSSD, LF, HF, LF n.u., HF n.u., LF/HF). Multiple linear regression models examined the relationship of HRV parameters with RCIs. RMSSD, LF n.u., HF n.u., LF/HF were significantly associated with PT. Specifically, the value of PT increased by 0.192 ± 0.091 or 0.231 ± 0.088 s, respectively for each 1 standard deviation (SD) increase in RMSSD or HF n.u.; it increased by 0.230 ± 0.088 or 0.215 ± 0.088 s, respectively for each 1 - SD decrease in LF n.u. or ln (LF/HF) (all P < 0.05). RMSSD was significantly associated with APTT, i.e., the value of APTT increased by 1.032 ± 0.470 s for each 1 - SD increase in RMSSD (P < 0.05). HRV parameters were associated with RCIs in patients with BC. These observations suggest that the autonomic nervous system and coagulation indices in BC patients are linked, potentially explaining the reason that they are both associated with the prognosis.
© 2021. The Author(s).

Entities:  

Year:  2021        PMID: 34326419     DOI: 10.1038/s41598-021-94931-w

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  47 in total

1.  Mechanism of the high coagulation state of breast cancer tissue factor.

Authors:  X-K Mi; Q-R Liu; L Zhu; M-X Sang; L-R Guo; B-E Shan
Journal:  Eur Rev Med Pharmacol Sci       Date:  2017-05       Impact factor: 3.507

2.  Evidence of altered autonomic cardiac regulation in breast cancer survivors.

Authors:  Chiara Vigo; Wolfgang Gatzemeier; Roberto Sala; Mara Malacarne; Armando Santoro; Massimo Pagani; Daniela Lucini
Journal:  J Cancer Surviv       Date:  2015-04-22       Impact factor: 4.442

3.  Higher vagal activity as related to survival in patients with advanced breast cancer: an analysis of autonomic dysregulation.

Authors:  Janine Giese-Davis; Frank H Wilhelm; Rie Tamagawa; Oxana Palesh; Eric Neri; Craig Barr Taylor; Helena C Kraemer; David Spiegel
Journal:  Psychosom Med       Date:  2015-05       Impact factor: 4.312

4.  Cardiac autonomic modulation impairments in advanced breast cancer patients.

Authors:  Claudia Arab; Luiz Carlos Marques Vanderlei; Laércio da Silva Paiva; Kyle Levi Fulghum; Carlos Elias Fristachi; Afonso Celso Pinto Nazario; Simone Elias; Luiz Henrique Gebrim; Celso Ferreira Filho; Yori Gidron; Celso Ferreira
Journal:  Clin Res Cardiol       Date:  2018-05-02       Impact factor: 5.460

Review 5.  Heart rate variability measure in breast cancer patients and survivors: A systematic review.

Authors:  Claudia Arab; Daniel Penteado Martins Dias; Renata Thaís de Almeida Barbosa; Tatiana Dias de Carvalho; Vitor Engrácia Valenti; Tânia Brusque Crocetta; Marcelo Ferreira; Luiz Carlos de Abreu; Celso Ferreira
Journal:  Psychoneuroendocrinology       Date:  2016-02-26       Impact factor: 4.905

6.  Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer.

Authors:  M Levine; J Hirsh; M Gent; A Arnold; D Warr; A Falanga; M Samosh; V Bramwell; K I Pritchard; D Stewart
Journal:  Lancet       Date:  1994-04-09       Impact factor: 79.321

7.  Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer.

Authors:  Luc Y Dirix; R Salgado; R Weytjens; C Colpaert; I Benoy; P Huget; P van Dam; A Prové; J Lemmens; P Vermeulen
Journal:  Br J Cancer       Date:  2002-02-01       Impact factor: 7.640

8.  Thrombotic biomarkers for risk prediction of malignant disease recurrence in patients with early stage breast cancer.

Authors:  Cinzia Giaccherini; Marina Marchetti; Giovanna Masci; Cristina Verzeroli; Laura Russo; Luigi Celio; Roberta Sarmiento; Sara Gamba; Carmen J Tartari; Erika Diani; Alfonso Vignoli; Paolo Malighetti; Daniele Spinelli; Carlo Tondini; Sandro Barni; Francesco Giuliani; Fausto Petrelli; Andrea D'Alessio; Giampietro Gasparini; Filippo De Braud; Armando Santoro; Roberto Labianca; Anna Falanga
Journal:  Haematologica       Date:  2019-09-26       Impact factor: 9.941

Review 9.  The potential benefits of low-molecular-weight heparins in cancer patients.

Authors:  Francisco Robert
Journal:  J Hematol Oncol       Date:  2010-01-14       Impact factor: 17.388

10.  Clinical and Prognostic Significance of Preoperative Plasma Fibrinogen Levels in Patients with Operable Breast Cancer.

Authors:  Yu Mei; Song Zhao; Xiaofei Lu; Haixia Liu; Xiangyi Li; Rong Ma
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.